Grifols S.A. — Investor Relations & Filings
Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2018-11-05 | English | |
| 6-K | 2018-11-02 | English | |
| 6-K | 2018-10-29 | English | |
| 6-K | 2018-10-03 | English | |
| 6-K | 2018-09-07 | English | |
| 6-K | 2018-08-01 | English |
Browse filings by year
23 years- 2026 17 filings
- 2025 46 filings
- 2024 117 filings
- 2023 40 filings
- 2022 37 filings
- 2021 68 filings
- 2020 51 filings
- 2019 25 filings
- 2018 28 filings
- 2017 33 filings
- 2016 24 filings
- 2015 29 filings
- 2014 32 filings
- 2013 36 filings
- 2012 33 filings
- 2011 44 filings
- 2010 15 filings
- 2009 3 filings
- 2008 2 filings
- 2007 1 filing
- 2006 1 filing
- 2004 1 filing
- 1994 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 12234587 | 6-K | 2018-11-05 | English | ||
| 12234588 | 6-K | 2018-11-02 | English | ||
| 12234589 | 6-K | 2018-10-29 | English | ||
| 12234590 | 6-K | 2018-10-03 | English | ||
| 12234591 | 6-K | 2018-09-07 | English | ||
| 12234592 | 6-K | 2018-08-01 | English | ||
| 12234593 | 6-K | 2018-07-27 | English | ||
| 12234594 | SC 13D/A | 2018-06-19 | English | ||
| 12234595 | 6-K | 2018-06-07 | English | ||
| 12234596 | 6-K | 2018-06-04 | English | ||
| 12234597 | 6-K | 2018-05-25 | English | ||
| 12234598 | 6-K | 2018-05-10 | English | ||
| 12234599 | 6-K | 2018-05-03 | English | ||
| 12234600 | 6-K | 2018-04-20 | English | ||
| 12234601 | 20-F | 2018-04-06 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Grifols S.A., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Grifols S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/1834/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=1834 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=1834 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=1834 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 1834}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Grifols S.A. (id: 1834)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.